Skołyszewski J, Weiss M
Acta Radiol Oncol. 1983;22(5):345-8. doi: 10.3109/02841868309134051.
The results of high-dose small-volume 60Co teletherapy in a series of 176 patients with carcinoma of the urinary bladder are reported. Five-year survival rates without evidence of disease were 26.9 per cent in stage B, 20.3 per cent in stage C, and 14.3 per cent in stage D. The most common cause of treatment failure was pelvic recurrence, which was observed alone in 58.2 per cent and together with distant metastases in 5.2 per cent of the patients.
报告了对176例膀胱癌患者进行大剂量小体积60钴远距离治疗的结果。B期无疾病证据的五年生存率为26.9%，C期为20.3%，D期为14.3%。治疗失败的最常见原因是盆腔复发，单独出现盆腔复发的患者占58.2%，同时伴有远处转移的患者占5.2%。
